Why So Few Women Get Help for Menopause — Even When Treatment Exists

By Your Health Magazine Contributor

Your Health Magazine Contributor

. https://YourHealthMagazine.net

More Women's Health & Beauty Articles

Why So Few Women Get Help for Menopause — Even When Treatment Exists

Menopause affects more than a million American women every year, and up to 75 percent of them experience symptoms like hot flashes and night sweats that can persist for years. Yet despite decades of medical advancement, most women going through it never receive treatment that could meaningfully help. The disconnect isn’t a lack of options — it’s a system that has struggled to connect women to the care that already exists.

Hormone therapy — one of the most effective tools available for menopause symptoms — has seen its use fall sharply over the past two decades. National prescription data shows hormone therapy use dropped from 4.4 percent in 2007 to just 1.7 percent in 2023 among women 40 and older. Even among women ages 50 to 59, the group most likely to benefit, only about 3.5 percent were using it in 2023. Researchers who track this data expected the opposite trend, assuming that rising public awareness of menopause would translate into more women seeking treatment. Instead, usage has stayed near its lowest point since the early 2000s.

The Legacy of a 20-Year-Old Study

To understand why, it helps to go back two decades. “A huge amount of this hesitation traces back to a single clinical trial from the early 2000s that initially raised alarm about hormone therapy and heart risk,” explained Jenna Moore. “What gets lost is that the data was later re-analyzed, and for many women — particularly those who start therapy close to the onset of menopause — the risks are much smaller than that early reporting suggested. But the fear never fully went away, even after the science moved on.”

That early scare created a kind of institutional memory that has outlasted the evidence behind it. An entire generation of physicians trained during the years when hormone therapy was treated as uniformly risky, and many never received updated education once the research was revisited. Patients absorbed the same caution secondhand, often from family members or media coverage that never caught up to the corrected findings. The result is a treatment that research consistently supports as safe and effective for many women, but one that remains broadly feared for reasons that no longer hold up.

Doctors Are Part of the Gap Too

The treatment gap isn’t only about patient hesitation — it’s also a training gap. Many physicians, including primary care doctors who are often a woman’s first point of contact, receive little formal education in menopause management during medical school or residency. That leaves patients describing real, disruptive symptoms to a doctor who may not have the specific expertise to evaluate whether hormone therapy, or any other treatment, is appropriate for them.

“I regularly see patients who’ve been told their symptoms are just something to push through,” explained Dr. Sundus Amena,. “Untreated menopause symptoms don’t just affect comfort — they affect sleep, mood, concentration, and in many cases a woman’s ability to function at work. This isn’t a minor inconvenience we should be telling people to tolerate for a decade.”

That framing matters because it shapes what happens in the exam room. A doctor who views menopause as an unavoidable phase to endure is far less likely to raise treatment options than one who views it as a medical transition worth actively managing.

Who Is — and Isn’t — Being Treated

The gap in care isn’t distributed evenly, either. Hormone therapy use remains consistently higher among white women than among Black, Hispanic, and Asian American women, pointing to disparities in access, referral patterns, and possibly trust in the healthcare system that compound the broader treatment gap. Women in these underserved groups may be navigating multiple barriers at once — less access to specialists, less representation in the research that shapes treatment guidelines, and a healthcare system that has historically underdiagnosed and undertreated their symptoms across many conditions, not just menopause.

Symptoms That Outlast Expectations

Part of the challenge is that menopause isn’t a brief transition for most women. A meaningful share of women experience symptoms for more than a decade, and hot flashes alone can persist for years once they begin. Many women enter the process expecting a short, manageable phase and are caught off guard when symptoms continue well beyond that, sometimes well into their sixties.

What’s Actually Changing

There are signs of movement, even if progress remains slow. Increased public conversation about menopause in recent years — through media coverage, workplace policy discussions, and patient advocacy — has pushed more women to seek care, even if treatment rates haven’t caught up yet. Medical organizations have also renewed efforts to update physician training, with the explicit goal of closing the gap between what the evidence supports and what’s actually offered in exam rooms.

The Bottom Line

For women currently navigating symptoms, both specialists point to the same underlying message: menopause discomfort is not something that has to simply be endured, and a lack of relief isn’t a sign that nothing can be done — it’s often a sign that the conversation with a provider needs to go further. Treatment exists, and for many women it’s both safer and more effective than outdated fears suggest. The work now is making sure it actually reaches the women who could benefit from it.